Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Long-Term Investments (2020 - 2025)

Historic Long-Term Investments for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $2.3 million.

  • Bioventus' Long-Term Investments rose 1764.1% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 1764.1%. This contributed to the annual value of $1.9 million for FY2024, which is 3976.44% down from last year.
  • Bioventus' Long-Term Investments amounted to $2.3 million in Q3 2025, which was up 1764.1% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Bioventus' Long-Term Investments ranged from a high of $78.5 million in Q3 2022 and a low of $1.7 million during Q2 2025
  • Over the past 5 years, Bioventus' median Long-Term Investments value was $3.2 million (recorded in 2024), while the average stood at $12.8 million.
  • Its Long-Term Investments has fluctuated over the past 5 years, first skyrocketed by 30284.35% in 2022, then tumbled by 9166.86% in 2023.
  • Quarter analysis of 5 years shows Bioventus' Long-Term Investments stood at $16.8 million in 2021, then crashed by 84.37% to $2.6 million in 2022, then grew by 19.84% to $3.1 million in 2023, then crashed by 39.76% to $1.9 million in 2024, then rose by 20.19% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q3 2025, $1.7 million for Q2 2025, and $1.8 million during Q1 2025.